AMICUS THERAPEUTICS, INC. — Director's Dealing 2022

Mar 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2022-03-04

Reporting Person: SBLENDORIO GLENN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-04	Common Stock	M	15000	$4.79	Acquired	59048	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-04	Stock Options (right to buy)	$4.79	M	15000	Disposed	2022-06-13	Common Stock (15000)	Direct

Footnotes

F1: All of the options were fully vested and exercisable as of the transaction date.